359 related articles for article (PubMed ID: 17270227)
1. Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.
Checkley AM; Pepin J; Gibson WC; Taylor MN; Jäger HR; Mabey DC
Trans R Soc Trop Med Hyg; 2007 May; 101(5):523-6. PubMed ID: 17270227
[TBL] [Abstract][Full Text] [Related]
2. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
[TBL] [Abstract][Full Text] [Related]
3. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
[TBL] [Abstract][Full Text] [Related]
4. [Melarsoprol].
Simon F
Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741
[No Abstract] [Full Text] [Related]
5. [Three patients with African sleeping sickness following a visit to Tanzania].
Mendonça Melo M; Rasica M; van Thiel PP; Richter C; Kager PA; Wismans PJ
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2552-6. PubMed ID: 12532670
[TBL] [Abstract][Full Text] [Related]
6. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome].
Pialoux G; Kernbaum S; Vachon F
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging findings in human African trypanosomiasis: a four-year follow-up study in a patient and review of the literature.
Kager PA; Schipper HG; Stam J; Majoie CB
Am J Trop Med Hyg; 2009 Jun; 80(6):947-52. PubMed ID: 19478256
[TBL] [Abstract][Full Text] [Related]
8. The treatment of human African trypanosomiasis.
Pépin J; Milord F
Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
[No Abstract] [Full Text] [Related]
9. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
Pérez Martín O; Lastre González M; Urban M; Shwalbach J
Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
[TBL] [Abstract][Full Text] [Related]
10. [2 epidemics of arsenical encephalopathy in the treatment of trypanosomiasis, Uganda, 1992-1993].
Ancelle T; Barret B; Flachet L; Moren A
Bull Soc Pathol Exot; 1994; 87(5):341-6. PubMed ID: 7496198
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
Poltera AA; Hochmann A; Lambert PH
Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886
[TBL] [Abstract][Full Text] [Related]
12. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania.
Kibona SN; Matemba L; Kaboya JS; Lubega GW
Trop Med Int Health; 2006 Feb; 11(2):144-55. PubMed ID: 16451338
[TBL] [Abstract][Full Text] [Related]
13. Melarsoprol and reactive encephalopathy in Trypanosoma brucei rhodesiense.
Arroz JO
Trans R Soc Trop Med Hyg; 1987; 81(2):192. PubMed ID: 3617176
[No Abstract] [Full Text] [Related]
14. Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis.
Pépin J; Mpia B
Trans R Soc Trop Med Hyg; 2006 May; 100(5):437-41. PubMed ID: 16483622
[TBL] [Abstract][Full Text] [Related]
15. Lethal African trypanosomiasis in a traveler: MRI and neuropathology.
Braakman HM; van de Molengraft FJ; Hubert WW; Boerman DH
Neurology; 2006 Apr; 66(7):1094-6. PubMed ID: 16606924
[TBL] [Abstract][Full Text] [Related]
16. Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda.
Odiit M; Kansiime F; Enyaru JC
East Afr Med J; 1997 Dec; 74(12):792-5. PubMed ID: 9557424
[TBL] [Abstract][Full Text] [Related]
17. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
18. An alternative form of melarsoprol in sleeping sickness.
Kennedy PG
Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910
[TBL] [Abstract][Full Text] [Related]
19. Attempt to correlate urine arsenic excretion with clinical course during melarsoprol therapy of patients with Rhodesian trypanosomiasis.
Harrison SM; Harris RW; Bales JD
Am J Trop Med Hyg; 1997 Jun; 56(6):632-6. PubMed ID: 9230794
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis.
Rodgers J; Bradley B; Kennedy PG
Parasitol Int; 2007 Dec; 56(4):321-4. PubMed ID: 17643344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
